Zevtera / Mabelio (ceftobiprole)

Indicaton

Acute bacterial skin and skin structure infections (ABSSSI)

Therapeutic indications

Infectious disease

Type of product

Small molecule

Table

Phase

Phase III completed
Partnering status

Not partnered

You may also be interested in

Regkirona (regdanvimab)

Regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (COVID-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19

Marketed

Cadazolid

Crohn's disease

Phase II started

Zevtera / Mabelio (ceftobiprole)

Staphylococcus aureus bacteremia

Phase III completed